These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2408675)

  • 1. Tangier disease apolipoprotein A-I compared with normal plasma A-I using monoclonal antibodies.
    Weech PK; Frohlich J; Marcel YL; N'Guyen TD; Milne RW
    Biochim Biophys Acta; 1985 Jul; 835(2):402-7. PubMed ID: 2408675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein A-I: deficiency in Tangier disease.
    Dumon MF; Clerc M; Clerc M
    Adv Exp Med Biol; 1988; 243():67-73. PubMed ID: 3146917
    [No Abstract]   [Full Text] [Related]  

  • 3. Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.
    Schmitz G; Assmann G; Rall SC; Mahley RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6081-5. PubMed ID: 6412234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal apoprotein A-I isoprotein composition in patients with Tangier disease.
    Zannis VI; Lees AM; Lees RS; Breslow JL
    J Biol Chem; 1982 May; 257(9):4978-86. PubMed ID: 7068673
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunochemical study of the plasma low and high density lipoproteins in Tangier disease.
    Dumon MF; Visvikis S; Manabe T; Clerc M
    FEBS Lett; 1986 May; 201(1):163-7. PubMed ID: 3086124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of lipoproteins and apolipoproteins in serum of a Tangier patient by micro-scale two-dimensional electrophoresis.
    Manabe T; Visvikis S; Dumon MF; Clerc M; Siest G
    Clin Chem; 1987 Apr; 33(4):468-72. PubMed ID: 3103952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma.
    Edelstein C; Gordon JI; Vergani CA; Catapano AL; Pietrini V; Scanu AM
    J Clin Invest; 1984 Sep; 74(3):1098-103. PubMed ID: 6432845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tangier disease: a structural defect in apolipoprotein A-I (apoA-I Tangier).
    Kay LL; Ronan R; Schaefer EJ; Brewer HB
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2485-9. PubMed ID: 6806810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).
    Schaefer EJ; Kay LL; Zech LA; Brewer HB
    J Clin Invest; 1982 Nov; 70(5):934-45. PubMed ID: 7130397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease).
    Alaupovic P; Schaefer EJ; McConathy WJ; Fesmire JD; Brewer HB
    Metabolism; 1981 Aug; 30(8):805-9. PubMed ID: 6790903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins.
    Schaefer EJ; Anderson DW; Zech LA; Lindgren FT; Bronzert TB; Rubalcaba EA; Brewer HB
    J Lipid Res; 1981 Feb; 22(2):217-28. PubMed ID: 6787156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma apolipoproteins in Tangier disease, as studied with two-dimensional electrophoresis.
    Visvikis S; Dumon MF; Steinmetz J; Manabe T; Galteau MM; Clerc M; Siest G
    Clin Chem; 1987 Jan; 33(1):120-2. PubMed ID: 3100093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
    Wang CS; Alaupovic P; Gregg RE; Brewer HB
    Biochim Biophys Acta; 1987 Jul; 920(1):9-19. PubMed ID: 3109493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charge-shift electrophoresis of apolipoproteins from normal humans and patients with Tangier disease.
    Utermann G; Beisiegel U
    FEBS Lett; 1979 Jan; 97(2):245-8. PubMed ID: 216585
    [No Abstract]   [Full Text] [Related]  

  • 15. Tangier disease. In vitro conversion of proapo-A-ITangier to mature APO-A-ITangier.
    Bojanovski D; Gregg RE; Brewer HB
    J Biol Chem; 1984 May; 259(10):6049-51. PubMed ID: 6725246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High density lipoprotein infusion and partial plasma exchange in Tangier disease.
    Assmann G; Smootz E
    Eur J Clin Invest; 1978 Jun; 8(3):131-5. PubMed ID: 211037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of the plasma very low and low density lipoproteins in Tangier disease.
    Heinen RJ; Herbert PN; Fredrickson DS
    J Clin Invest; 1978 Jan; 61(1):120-32. PubMed ID: 201668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein A-I from normal human plasma: definition of three distinct antigenic determinants.
    Weech PK; Milne RW; Milthorp P; Marcel YL
    Biochim Biophys Acta; 1985 Jul; 835(2):390-401. PubMed ID: 2408674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of high-density lipoprotein apolipoproteins in Tangier disease.
    Schaefer EJ; Blum CB; Levy RI; Jenkins LL; Alaupovic P; Foster DM; Brewer HB
    N Engl J Med; 1978 Oct; 299(17):905-10. PubMed ID: 211412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of Tangier disease].
    Kosaka A; Hayashi H
    Rinsho Byori; 1988 Aug; 36(8):988-91. PubMed ID: 3149352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.